Pharmaceutical Sources

Latest News for: Pharmaceutical sources

Edit

Minnesota Capitol sees change in addressing opioid crisis

Waco Tribune-Herald 17 Feb 2019

Yet lobbying by the pharmaceutical industry blocked passage of increased registration fees for drug makers and distributors that would have raised $20 million a year to pay for the programs ... "I'd like to express my frustration about some of the conversations that are happening around the funding source," Gomez said....

Edit

AVEO Oncology Announces Oral Presentation of TIVO-3 Trial Topline Results at the 2019 ASCO Genitourinary ...

The Saratogian 17 Feb 2019

A copy of the presentation will be available in the Publications & Presentation section of the Company’s website. This press release features multimedia ... Figure 1 ... Rini ... AVEO Pharmaceuticals, Inc ... 1 ... 2 ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20190216005008/en/ ... HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL. SOURCE....

Edit

KEYTRUDA® (pembrolizumab) in Combination with Inlyta® (axitinib) Reduced Risk of Death by Nearly Half Compared ...

Waco Tribune-Herald 17 Feb 2019

View source version on businesswire.com.https.//www.businesswire.com/news/home/20190216005013/en/ ... HEALTH BIOTECHNOLOGY CLINICAL TRIALS ONCOLOGY PHARMACEUTICAL FDA GENERAL HEALTH. SOURCE....

Edit

Company Profile for Novus Therapeutics, Inc.

Waco Tribune-Herald 16 Feb 2019

--(BUSINESS WIRE)--Feb 15, 2019--Novus Therapeutics, Inc. (“Novus”) is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”) ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20190215005600/en/. KEYWORD ... HEALTH PHARMACEUTICAL. SOURCE ... PUB....

Edit

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Odessa American 16 Feb 2019

LOS ANGELES--(BUSINESS WIRE)--Feb 15, 2019--Puma Biotechnology, Inc. (NASDAQ ... About Puma Biotechnology. Puma Biotechnology, Inc ... Neratinib, oral was approved by the U.S ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20190215005542/en/. CONTACT. Alan H ... KEYWORD ... HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL. SOURCE ... PUB ... .......

Edit

U.S. and EU Patent Office Decisions Invalidate Amgen Subsidiary Immunex's Patents Claiming Antibodies to the ...

The Record 16 Feb 2019

Regeneron Pharmaceuticals, Inc ... About Regeneron Pharmaceuticals, Inc ... Forward-Looking Statements and Use of Digital Media This press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc ... SOURCE Regeneron Pharmaceuticals, Inc....

Edit

2-Day Seminar: Aseptic Processing & Validation in the Manufacture of Biotech & Pharmaceutical Products (San ...

Odessa American 15 Feb 2019

Aseptic Processing and Validation in the Manufacture of Biotech and Pharmaceutical Products" training has been added to ResearchAndMarkets.com's offering ... The role of environmental monitoringTypes & sources of microorganismsThe impact of microorganisms on product and patient health and safety ... Related Topics.Pharmaceutical Manufacturing ... SOURCE....

Edit

Narcolepsy - Pipeline Insights, 2019 - ResearchAndMarkets.com

Odessa American 15 Feb 2019

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type ... NLS PharmaJazz Pharmaceuticals Inc.Avadel PharmaceuticalsTaisho Pharmaceutical Co ... SOURCE....

Edit

Nasopharyngeal Cancer - Pipeline Insight, 2019 - ResearchAndMarkets.com

Odessa American 15 Feb 2019

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type ... Ltd.Atara Biotherapeutics Inc.AVEO Pharmaceuticals Inc.BeiGene Ltd.Betta Pharmaceuticals Co....

Edit

Phio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief Executive Officer Effective March 1

Market Watch 15 Feb 2019

15, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp ... Cauwenbergh was elected President and CEO of Phio Pharmaceuticals when the business was spun-off from its parent company, then known as Galena Biopharma, Inc., in April 2012 ... Dispersyn has accepted this new responsibility as CEO of Phio Pharmaceuticals ... SOURCE Phio Pharmaceuticals Corp....

Edit

Portal Hypertension - Pipeline Insight, 2019 by Developmental Stage, Associated Indications, Route of Administration and ...

Odessa American 15 Feb 2019

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type ... HEALTH CARDIOLOGY PHARMACEUTICAL. SOURCE....

Edit

Votubia - Drug Insight, 2019 - ResearchAndMarkets.com

Odessa American 15 Feb 2019

Scope ... Reasons to Buy ... Topics Covered. 1. Report Introduction. 2. Votubia - Overview ... 3 ... 4 ... 5 ... 6 ... Active Pharmaceutical Ingredient (API) Manufacturers by CountryActive Pharmaceutical Ingredient (API) Manufacturers by Region ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20190215005393/en/ ... HEALTH ONCOLOGY PHARMACEUTICAL. SOURCE....

Edit

Multaq - Drug Insight, 2019-2021: Historical & Forecasted Sales Analysis - ResearchAndMarkets.com

Odessa American 15 Feb 2019

Scope ... Reasons to Buy ... Topics Covered. 1. Report Introduction. 2. Multaq - Overview ... 3. Product Details ... Active Pharmaceutical Ingredient (API) Manufacturers by CountryActive Pharmaceutical Ingredient (API) Manufacturers by Region ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20190215005403/en/ ... HEALTH PHARMACEUTICAL. SOURCE....